HomePSTV • NASDAQ
add
Plus Therapeutics Inc
$0.45
Makalipas ang Oras ng Trabaho:(0.51%)-0.0023
$0.45
Sarado: Set 12, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$0.47
Sakop ng araw
$0.44 - $0.47
Sakop ng taon
$0.16 - $2.31
Market cap
44.39M USD
Average na Volume
11.58M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.39M | 8.68% |
Gastos sa pagpapatakbo | 1.68M | -23.65% |
Net na kita | 5.15M | 275.20% |
Net profit margin | 370.58 | 261.21% |
Kita sa bawat share | -0.01 | 98.56% |
EBITDA | -1.46M | 58.58% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 6.88M | -18.45% |
Kabuuang asset | 10.35M | -7.69% |
Kabuuang sagutin | 7.32M | -61.16% |
Kabuuang equity | 3.03M | — |
Natitirang share | 99.26M | — |
Presyo para makapag-book | 15.66 | — |
Return on assets | -34.32% | — |
Return on capital | 37.44% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 5.15M | 275.20% |
Cash mula sa mga operasyon | -5.80M | -404.17% |
Cash mula sa pag-invest | -4.63M | -21.83% |
Cash mula sa financing | 2.80M | -59.84% |
Net change in cash | -7.63M | -479.61% |
Malayang cash flow | -5.31M | -186.64% |
Tungkol
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®. Wikipedia
Itinatag
1996
Headquarters
Website
Mga Empleyado
21
